Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
- To determine the activity and efficacy of the schema specified as dose regimen
- To determine the safety and tolerability of the oxaliplatin-cisplatin and 5FU